Intrinsic Value

Cytokinetics, Incorporated (CYTK)

$65.34

+0.54 (+0.83%)

Enterprise Value -4,606.87
Net Debt 642.37
Equity Value -5,249.24
Shares Outstanding 96.52
Equity Value Per Share -54.38



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt